Suchergebnisse - "Chiricozzi, A"

PubPharm (63)

41

Italian guidelines on the systemic treatments of moderate‐to‐severe plaque psoriasis

enthalten in: Journal of the European Academy of Dermatology and Venereology | 2017

von Gisondi, P. | Altomare, G. | Ayala, F. | +17

42

Potential correlation of wound bed score and biomarkers in chronic lower leg wounds: an exploratory study

enthalten in: Journal of wound care | 2017

von Dini, V. | Papadia, F. | Francesco, F. | +5

43

Increased levels of IL-17 in tear fluid of moderate-to-severe psoriatic patients is reduced by adalimumab therapy

enthalten in: Journal of the European Academy of Dermatology and Venereology : JEADV | 2016

von Chiricozzi, A. | Cannizzaro, M. | Salandri, G. | +8

44

A revolutionary therapeutic approach for psoriasis : bispecific biological agents

enthalten in: Expert opinion on investigational drugs | 2016

von Torres, T. | Romanelli, M. | Chiricozzi, A.

ErratumIn: Expert Opin Investig Drugs. 2016 Nov;25(11):1353. - PMID 27762154

45

Increased expression of interleukin-17 pathway genes in nonlesional skin of moderate-to-severe psoriasis vulgaris

enthalten in: The British journal of dermatology | 2016

von Chiricozzi, A. | Suárez-Fariñas, M. | Fuentes-Duculan, J. | +5

CommentIn: Br J Dermatol. 2016 Jan;174(1):19-20. - PMID 26790651

46

A revolutionary therapeutic approach for psoriasis: bispecific biological agents

enthalten in: Expert opinion on investigational drugs | 2016

von Torres, T. | Romanelli, M. | Chiricozzi, A.

47

Increased expression of interleukin‐17 pathway genes in nonlesional skin of moderate‐to‐severe psoriasis vulgaris

enthalten in: The British journal of dermatology | 2016

von Chiricozzi, A. | Suárez‐Fariñas, M. | Fuentes‐Duculan, J. | +5

48

Real-life 9-year experience with adalimumab in psoriasis and psoriatic arthritis: results of a single-centre, retrospective study

enthalten in: Journal of the European Academy of Dermatology and Venereology | 2016

von Chiricozzi, A. | Zangrilli, A. | Bavetta, M. | +3

49

A revolutionary therapeutic approach for psoriasis: bispecific biological agents

enthalten in: Expert opinion on investigational drugs | 2016

von Torres, T. | Romanelli, M. | Chiricozzi, A.

50

Increased levels of IL‐17 in tear fluid of moderate‐to‐severe psoriatic patients is reduced by adalimumab therapy

enthalten in: Journal of the European Academy of Dermatology and Venereology | 2016

von Chiricozzi, A. | Cannizzaro, M. | Salandri, G. | +8